Current Perspectives on HIV-1 Antiretroviral Drug Resistance
AbstractCurrent advancements in antiretroviral therapy (ART) have turned HIV-1 infection into a chronic and manageable disease. However, treatment is only effective until HIV-1 develops resistance against the administered drugs. The most recent antiretroviral drugs have become superior at delaying the evolution of acquired drug resistance. In this review, the viral fitness and its correlation to HIV-1 mutation rates and drug resistance are discussed while emphasizing the concept of lethal mutagenesis as an alternative therapy. The development of resistance to the different classes of approved drugs and the importance of monitoring antiretroviral drug resistance are also summarized briefly. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Iyidogan, P.; Anderson, K.S. Current Perspectives on HIV-1 Antiretroviral Drug Resistance. Viruses 2014, 6, 4095-4139.
Iyidogan P, Anderson KS. Current Perspectives on HIV-1 Antiretroviral Drug Resistance. Viruses. 2014; 6(10):4095-4139.Chicago/Turabian Style
Iyidogan, Pinar; Anderson, Karen S. 2014. "Current Perspectives on HIV-1 Antiretroviral Drug Resistance." Viruses 6, no. 10: 4095-4139.